March 01, 2022

Worthington Resumes Attendance at 2022 Global Scientific Conferences

After a long pause caused by the COVID pandemic Worthington is exhibiting at a number of annual scientific meetings.

LAKEWOOD, NJ (March 1, 2022) – Worthington is pleased to announce that after hosting a number of virtual exhibits during the COVID pandemic, they will now be exhibiting at global scientific meetings and conferences on location. These annual meetings will include EB ’22, AACR ‘22, AAI ’22, ISSCR ’22, SFN ’22 and Cell Biology. Please visit the events section of the Worthington website for full details.

“Although we were able to support many societies with our virtual exhibit activities during the pandemic, we are excited to be able to visit with customers and business partners in-person,” said Jim Zacka, vice president at Worthington. “We believe these meetings are an excellent way to follow scientific trends and keep an open line of communications with our core markets and customers.”

In addition, Worthington will be represented at a number of local shows and in- house product fairs. Please contact your local Worthington account representative for ongoing support via email at custservice@worthington-

About Worthington Biochemical Corporation

Founded in 1947, Worthington Biochemical Corporation is an industry leader in the development and production of high-quality purified enzymes, proteins, nucleic acids and cell isolation kits for life science research, diagnostics and biotechnology applications. An ISO9001 Certified, primary manufacturer Worthington meets enzyme requirements from research to large-scale bulk bioprocessing and OEM applications. Worthington Biochemical Corporation is a privately held company, headquartered in Lakewood, NJ and has worldwide distribution through a network of distributors.

For more information, contact:

March 01, 2022